NextGen 2024: Refractory SJIA & MAS Session Part 7
NextGen 2024: Refractory SJIA & MAS Session Part 7
AI Summary
Bulleted
Text
Key Insights
- Focus on next-generation therapies for Systemic Juvenile Idiopathic Arthritis (SJIA), Still's disease, and Macrophage Activation Syndrome (MAS).
- Case studies of two pediatric patients: one with ATS presenting with Still's onset and MAS and another with JMA also presenting with Still's onset.
- Treatment approaches including antiviral prophylaxis, antibacterial prophylaxis, IV MP pulses, and various medications like Anakinra, Tocilizumab, Tacrolimus, and Baricitinib are employed.
- Patient monitoring involves tracking markers like WBC, ESR, CRP, ferritin, and LFT, with NGS panel for AID (Heterozygous DNASE2 c.995C>A VUS and PSMB8 c.-5C>T VUS) and PID performed.
#stillsdisease
#sjiafoundation
#macrophageactivation
#sjia
#curesjia
Explore the complexities of refractory Still's disease and macrophage activation syndrome (MAS) in pediatric rheumatology. This overview delves into clinical trials, diagnostic approaches, and therapeutic options, emphasizing the importance of personalized treatment strategies for improved patient outcomes.
#stillsdisease
#sjiafoundation
#macrophageactivation
#sjia
#curesjia

1/4

2/4

3/4

4/4
NextGen 2024: Refractory SJIA & MAS Session Part 7
- 1. Refractory disease (Still’s +/- MAS) Juan Manuel Mosquera A. Pediatric Rheumatologist Attending physician at Pediatric Rheumatology section in Sant Joan de Déu Children’s Hospital
- 2. • ATS, 11 yr, , 33 kg, latino origin • Cholinergic urticaria and atopic dermatitis • Typical Still onset – MAS (Fever, arthralgia, sore throat, rash) • ↑WBC, ESR, CRP, ferritin, LFT, S100A8/A9, IL18 and triglycerids, ↓ PLT, fibrinogen. HLA-DRB1*15 • NGS panel for AID (Heterozygous DNASE2 c.995C>A VUS and PSMB8 c.-5C>T VUS) and PID performed • HRCT negative • Antiviral and antibacterial prophylaxis CS + ANK + CsA + IVIG Emapalumab (+CS + ANK + CsA) CS + ANK + CsA TCZ + CsA (+CS) TCZ (+CS) TK + IVIG (+TCZ + CS) SARS-CoV2 CMV reactivation Adenovirus SARS-CoV2 Adenovirus CMV reactivation Rhino/Enterovirus Rhino/Enterovirus Rhino/Enterovirus
- 3. • JMA, , 13 yr, 45 kg, Philippine origin. Any relevant past history • Typical Still disease onset (fever, sore throat, myalgia, rash, serositis, w/o arthritis) • ↑WBC, ESR, CRP, ferritin, LFT, S100A8/A9, IL18 and 🡪 PLT, fibrinogen, triglycerids. HLA-DRB1*15 • HRCT negative • DRESS like reaction (26/05/24) 🡪 Rash and ↑LFT IV MP pulses + oral CS Anakinra 2,2 mg/kg (+ CS) Tocilizumab 8 mg/kg (+ CS) Tacrolimus 0,1 mg/kg (+ CS) Baricitinib 4 mg/d (+ TK + CS)
- 4. Juanmanuel.mosquera@sjd.es Enfermedades Autoinmunes y Autoinflamatorias XUEC en malalties autoimmunes sistèmiques I autoinflamatòries
Related Jaunts

NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1
@SJIA_Foundation
3 months ago •
266 views

NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
3 months ago •
365 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
@SJIA_Foundation
3 months ago •
519 views

NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 2
@SJIA_Foundation
3 months ago •
250 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
@SJIA_Foundation
3 months ago •
278 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
3 months ago •
289 views
More from author

NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
3 months ago •
365 views

NextGen 2024: Weaning meds when disease is controlled Session Part 1
@SJIA_Foundation
3 months ago •
279 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
3 months ago •
289 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
@SJIA_Foundation
3 months ago •
278 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
@SJIA_Foundation
3 months ago •
238 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4
@SJIA_Foundation
3 months ago •
247 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3
@SJIA_Foundation
3 months ago •
244 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 2
@SJIA_Foundation
3 months ago •
248 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
@SJIA_Foundation
3 months ago •
519 views